Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CXRX

(CXRX) (CXRX) Stock Price, News & Analysis

(CXRX) logo

About (CXRX) Stock (NASDAQ:CXRX)

Advanced Chart

Key Stats

Today's Range
$0.19
$0.21
50-Day Range
$0.19
$0.19
52-Week Range
$0.19
$1.80
Volume
648,890 shs
Average Volume
267,843 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CXRX) and its competitors with MarketBeat's FREE daily newsletter.

CXRX Stock News Headlines

Rangers aim to 'silence the crowd'
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
How will you remember Henderson?
Spoony scoops in £160,000 from World Cup
Zoo names Penguins after Brighton stars
See More Headlines

CXRX Stock Analysis - Frequently Asked Questions

(CXRX) (NASDAQ:CXRX) announced its quarterly earnings results on Friday, August, 12th. The company reported $1.38 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.38. The company's revenue was up 208.1% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that (CXRX) investors own include Intact Financial (IFC), Constellation Software (CSU), Concordia International (CXR), HudBay Minerals (HBM), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B) and First Quantum Minerals (FM).

Company Calendar

Last Earnings
8/12/2016
Today
7/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CXRX
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:CXRX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners